Kaiku Health has appointed Professor Vesa Kataja as the Chief Medical Officer of Kaiku Health. He will join the team full-time in February 2020. Prof. Vesa Kataja is a seasoned specialist in Oncology and Radiotherapy and Adjunct Professor in Clinical Oncology. For the last five years he has worked as the Chief Medical Director at...
Kaiku Health will provide digital health interventions based on patient-reported outcomes to cancer patients treated with chemotherapy, immunotherapy and combination therapies in several cancer types. Kaiku Health is strengthening its foothold in Central Europe as the Geneva University Hospitals (HUG) in Switzerland and University Hospital Schleswig-Holstein Lübeck in Germany will implement Kaiku Health in the...
Sippola is one of the 35 young innovators in Europe recognised by the annual MIT Technology Review nomination. He was awarded in the Entrepreneur category on his work in founding and leading Kaiku Health, a digital therapeutics platform used in cancer care. The 35 winners of 2019 were selected among over 1000 candidates by a...
Kaiku Health and Oulu University Hospital have jointly published a research investigating the feasibility of machine learning in predicting symptoms of patients undergoing Immune Checkpoint Inhibitor (ICI) treatments. The study is the first of its kind and the results were published at the ESMO Immuno-Oncology Congress 2019 in Geneva on December 12. The results indicate...
The abstract to be presented at the congress is based on research conducted in collaboration between Oulu University Hospital and Kaiku Health. The research investigates a method of utilizing advanced analytics and machine learning in order to predict the onset and continuity of symptoms in patients receiving immune checkpoint inhibitor treatments. The prediction model was...